Sophie Lanzkron

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi request reprint Polymerized human Hb use in acute chest syndrome: a case report
    Sophie Lanzkron
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Transfusion 42:1422-7. 2002
  2. ncbi request reprint A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease
    Carlton Haywood
    Johns Hopkins Berman Institute of Bioethics, Johns Hopkins University School of Medicine, Division of Hematology, 2024 E Monument St, Rm 2 521, Baltimore, MD 21287, USA
    J Natl Med Assoc 101:1022-33. 2009
  3. pmc Mortality rates and age at death from sickle cell disease: U.S., 1979-2005
    Sophie Lanzkron
    Johns Hopkins School of Medicine, Department of Medicine, Baltimore, MD 21205, USA
    Public Health Rep 128:110-6. 2013
  4. doi request reprint Examining the effectiveness of hydroxyurea in people with sickle cell disease
    Sophie Lanzkron
    Div of Hematology, Dept of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument Street, Suite 7300, Baltimore, MD 21205, USA
    J Health Care Poor Underserved 21:277-86. 2010
  5. ncbi request reprint Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network
    Sophie Lanzkron
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Natl Med Assoc 100:968-73. 2008
  6. ncbi request reprint Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea
    Sophie Lanzkron
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Am J Hematol 81:927-32. 2006
  7. doi request reprint Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children
    John J Strouse
    Department of Pediatrics, Johns Hopkins University School of Medicine, Division of Pediatric Hematology, 720 Rutland Ave, Ross 1125, Baltimore, MD 21205, USA
    Pediatrics 122:1332-42. 2008
  8. pmc Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease
    Carlton Haywood
    Department of Medicine, Division of Hematology, The Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA
    Am J Hematol 86:85-7. 2011
  9. pmc Hospital self-discharge among adults with sickle-cell disease (SCD): associations with trust and interpersonal experiences with care
    Carlton Haywood
    Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    J Hosp Med 5:289-94. 2010
  10. pmc A video-intervention to improve clinician attitudes toward patients with sickle cell disease: the results of a randomized experiment
    Carlton Haywood
    Division of Hematology, The Johns Hopkins University School of Medicine, The Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA
    J Gen Intern Med 26:518-23. 2011

Detail Information

Publications23

  1. ncbi request reprint Polymerized human Hb use in acute chest syndrome: a case report
    Sophie Lanzkron
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Transfusion 42:1422-7. 2002
    ..Transfusion therapy has been shown to significantly increase oxygenation in patients with ACS and RBC exchange is considered the standard of care in patients at high risk of respiratory failure...
  2. ncbi request reprint A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease
    Carlton Haywood
    Johns Hopkins Berman Institute of Bioethics, Johns Hopkins University School of Medicine, Division of Hematology, 2024 E Monument St, Rm 2 521, Baltimore, MD 21287, USA
    J Natl Med Assoc 101:1022-33. 2009
    ....
  3. pmc Mortality rates and age at death from sickle cell disease: U.S., 1979-2005
    Sophie Lanzkron
    Johns Hopkins School of Medicine, Department of Medicine, Baltimore, MD 21205, USA
    Public Health Rep 128:110-6. 2013
    ..Whether similar improvements for adults with the disease have occurred is unknown. We investigated mortality rates for children and adults with SCD...
  4. doi request reprint Examining the effectiveness of hydroxyurea in people with sickle cell disease
    Sophie Lanzkron
    Div of Hematology, Dept of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument Street, Suite 7300, Baltimore, MD 21205, USA
    J Health Care Poor Underserved 21:277-86. 2010
    ..2,017, p=.031). Hydroxyurea was underutilized in this patient population. Patients with more regular refills of hydroxyurea had fewer admissions to the hospital and markedly decreased costs...
  5. ncbi request reprint Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network
    Sophie Lanzkron
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Natl Med Assoc 100:968-73. 2008
    ..006). The results of this survey suggest that lack of awareness, agreement and belief in the benefits of hydroxyurea contributes to providers underprescribing hydroxyurea...
  6. ncbi request reprint Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea
    Sophie Lanzkron
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Am J Hematol 81:927-32. 2006
    ..Hospital utilization among adults with SCA has increased significantly. There are likely many factors that have played a role in this increase. One factor that appears to be involved is the underutilization of HU...
  7. doi request reprint Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children
    John J Strouse
    Department of Pediatrics, Johns Hopkins University School of Medicine, Division of Pediatric Hematology, 720 Rutland Ave, Ross 1125, Baltimore, MD 21205, USA
    Pediatrics 122:1332-42. 2008
    ..Hydroxyurea is the only approved medication for the treatment of sickle cell disease in adults; there are no approved drugs for children...
  8. pmc Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease
    Carlton Haywood
    Department of Medicine, Division of Hematology, The Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA
    Am J Hematol 86:85-7. 2011
    ..A deeper understanding of patient perspectives toward HU utilization is required as part of multipronged efforts to combat its underutilization in the treatment of SCD...
  9. pmc Hospital self-discharge among adults with sickle-cell disease (SCD): associations with trust and interpersonal experiences with care
    Carlton Haywood
    Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    J Hosp Med 5:289-94. 2010
    ....
  10. pmc A video-intervention to improve clinician attitudes toward patients with sickle cell disease: the results of a randomized experiment
    Carlton Haywood
    Division of Hematology, The Johns Hopkins University School of Medicine, The Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA
    J Gen Intern Med 26:518-23. 2011
    ..Negative attitudes toward adults with sickle cell disease have been identified as an important barrier to the receipt of appropriate pain management for this patient population...
  11. pmc Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease
    Sophie Lanzkron
    School of Medicine, Johns Hopkins University, 1830 East Monument Street, Suite 7300, Baltimore, MD 21205, USA
    Ann Intern Med 148:939-55. 2008
    ..Hydroxyurea is the only approved drug for treatment of sickle cell disease...
  12. pmc Religious coping and hospital admissions among adults with sickle cell disease
    Shawn M Bediako
    Department of Psychology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA
    J Behav Med 34:120-7. 2011
    ..29, P < .05). These results indicate a need for further investigation of the roles that religion and spirituality play in adjustment to sickle cell disease and their influence on health care utilization patterns and health outcomes...
  13. pmc Venous Thromboembolism in Adults with Sickle Cell Disease: A Serious and Under-recognized Complication
    Rakhi P Naik
    Department of Medicine, Division of Hematology, Johns Hopkins University, Baltimore, Md Electronic address
    Am J Med 126:443-9. 2013
    ..The purpose of this study was to establish the prevalence and risk factors for venous thromboembolism in a large cohort of patients with sickle cell disease and determine the relationship between venous thromboembolism and mortality...
  14. pmc The impact of race and disease on sickle cell patient wait times in the emergency department
    Carlton Haywood
    Department of Medicine, Division of Hematology, The Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
    Am J Emerg Med 31:651-6. 2013
    ....
  15. doi request reprint Prediction of onset and course of high hospital utilization in sickle cell disease
    C Patrick Carroll
    Department of Psychiatry and Behavioral Sciences, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    J Hosp Med 6:248-55. 2011
    ..Although sickle cell disease (SCD) patients typically manage their pain at home, a small subgroup is frequently hospitalized and accounts for the majority of costs...
  16. pmc The association of provider communication with trust among adults with sickle cell disease
    Carlton Haywood
    Division of Hematology, The Johns Hopkins University School of Medicine, The Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA
    J Gen Intern Med 25:543-8. 2010
    ..Adults with sickle cell disease often report poor interpersonal healthcare experiences, including poor communication with providers. However, the effect of these experiences on patient trust is unknown...
  17. pmc The excess burden of stroke in hospitalized adults with sickle cell disease
    John J Strouse
    Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Hematol 84:548-52. 2009
    ..Stroke in SCD is associated with several known adult risk factors for ischemic and hemorrhagic stroke. Studies for the primary and secondary prevention of stroke in adults with SCD are urgently needed...
  18. pmc A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients
    Patrick C Carroll
    Department of Psychiatry and Behavioral Sciences, The Johns Hopkins School of Medicine, Baltimore, MA, USA
    Clin J Pain 29:317-23. 2013
    ..To identify demographic, medical, and psychosocial characteristics that distinguished sickle cell disease (SCD) patients who were frequent utilizers of urgent or emergent care resources from low-utilizing patients...
  19. ncbi request reprint High prevalence and correlates of low bone mineral density in young adults with sickle cell disease
    Redonda G Miller
    Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, MD 21287, USA
    Am J Hematol 81:236-41. 2006
    ..02), and low serum zinc concentrations (P < 0.01). The prevalence of osteopenia and osteoporosis in young adults with SCD is extremely high. Further research is needed to address fracture risk and therapeutic interventions...
  20. pmc The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease
    John J Strouse
    Division of Pediatric Hematology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Expert Rev Hematol 4:597-606. 2011
    ....
  21. doi request reprint Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia
    Kenneth I Ataga
    Division of Hematology Oncology, University of North Carolina at Chapel Hill, CB no 7305, 3009 Old Clinic Bldg, Chapel Hill, NC 27599 7305, USA
    Blood 111:3991-7. 2008
    ..This study is registered at http://clinicaltrials.gov as NCT00040677...
  22. pmc The association between sickle cell disease and dental caries in African Americans
    Brian Laurence
    Department of Restorative Services, Howard University College of Dentistry, Washington, DC, USA
    Spec Care Dentist 26:95-100. 2006
    ..05) after adjusting for age and gender. The results suggest that low-income African Americans with SCD may be at increased risk for dental caries and are less likely to receive treatment with a restoration...
  23. ncbi request reprint Self-perceived loss of control and untreated dental decay in African American adults with and without sickle cell disease
    Brian Laurence
    Howard University College of Dentistry, Washington, DC 20059, USA
    J Health Care Poor Underserved 17:641-51. 2006
    ..This study showed that higher dental external locus of control is associated with increased untreated tooth decay, both for African Americans with and without SCD and that the magnitude of the association did not differ across groups...